Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy

Brain

Volumn 134, Issue 11, 2011, Pages 3326-3332

  Garone, Caterina ^a,b,c   Tadesse, Saba ^a   Hirano, Michio ^a  

^a Department of Medicine   (United States)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

BMT; encephalomyopathy; mitochondrial disease; MNGIE; TYMP

Indexed keywords

PHOSPHORYLASE; THYMIDINE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD BUFFY COAT; CACHEXIA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DISEASE COURSE; DOMINICAN REPUBLIC; ENVIRONMENTAL FACTOR; EUROPE; FEMALE; GASTROINTESTINAL MOTILITY DISORDER; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; GENOTYPE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LEUKODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC DISORDER; MNGIE SYNDROME; MORTALITY; PANCREAS EXOCRINE INSUFFICIENCY; PERIPHERAL NEUROPATHY; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; TYMPANIC TEMPERATURE;

EID: 81055133547     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr245     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: Author 2000.
2. Chang TM, Chi CS, Tsai CR, Lee HF, Li MC. Paralytic ileus in MELAS with phenotypic features of MNGIE. Pediatr Neurol 2004; 31: 374-7.
3. Davidson MM, Walker WF, Hernandez-Rosa E, Nesti C. Evidence for nuclear modifier gene in mitochondrial cardiomyopathy. J Mol Cell Cardiol 2009; 46: 936-42.
4. Eccleston PA, Funa K, Heldin CH. Neurons of the peripheral nervous system express thymidine phosphorylase. Neurosci Lett 1995; 192: 137-41.
5. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, et al. Platelet-derived endothelial cell growth factor/thymidine phos-phorylase expression in normal tissue: an immunohistochemical study. J Pathol 1995; 176: 183-190.
6. Halter J, Schüpbach WM, Casali C, Elhasid R, Fay K, Hammans S, et al. Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 2011; 46: 330-7.
7. Hirano M, Marti R, Casali C, Tadesse S, Uldrick T, Fine B, et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006; 67: 1458-60. (Pubitemid 44632073)
8. Hirano M, Nishigaki Y, Martí R. MNGIE: a disease of two genomes. Neurologist 2004; 10: 8-17.
9. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994; 44: 721-7. (Pubitemid 24130006)
10. Hirano M, Yebenes J, Jones AC, Nishino I, DiMauro S, Carlo JR, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet 1998; 63: 526-33. (Pubitemid 30418634)
11. Kintarak J, Liewluck T, Sangruchi T, Hirano M, Kulkantrakorn K, Muengtaweepongsa S. A novel ECGF1 mutation in a Thai patient with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Clin Neurol Neurosurg 2007; 109: 613-6. (Pubitemid 47016755)
12. Lara MC, Weiss B, Illa I, Madoz P, Massuet L, Andreu A, et al. Infusion of platelets transiently reduces nucleoside overload in MNGIE. Neurology 2006; 67: 1461-3. (Pubitemid 44632074)
13. López LC, Akman HO, Garcia-Cazorla A, Dorado B, Marti R, Nishino I, et al. Unbalanced deoxynucleotide pools cause mitochondrial DNA instability in thymidine phosphorylase deficient mice. Hum Mol Genet 2009, 18, 714-22.
14. MartíR, Nishigaki Y, Hirano M. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency. Biochem Biophys Res Commun 2003, 303, 14-8.
15. Marti R, Spinazzola A, Tadesse S, Nishino I, Nishigaki Y, Hirano M. Definitive diagnosis of mitochondrial neurogastrointestinal encephalo-myopathy by biochemical assays. Clin Chem 2004; 50: 120-4. (Pubitemid 38125707)
16. MartíR, Verschuuren JJ, Buchman A, Hirano I, Tadesse S, van Kuilenburg AB, et al. Late-onset MNGIE due to partial loss of thymi-dine phosphorylase activity. Ann Neurol 2005, 58, 649-52.
17. Matsukawa K, Moriyama A, Kawai Y, Asai K, Kato T. Tissue distribution of human gliostatin/platelet-derived endothelial cell growth factor (PD-ECGF) and its drug-induced expression. Biochim Biophys Acta 1996; 1314: 71-82. (Pubitemid 26395501)
18. Nishigaki Y, Marti R, Copeland WC, Hirano M. Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phos-phorylase deficiency. J Clin Invest 2003; 111: 1913-21. (Pubitemid 38057736)
19. Nishigaki Y, MartíR, Hirano M. ND5 is a hot-spot for multiple atypical mitochondrial DNA deletions in mitochondrial neurogastrointestinal encephalomyopathy. Hum Mol Genet 2004; 13: 91-101. (Pubitemid 38072138)
20. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999; 283: 689-92.
21. Nishino I, Spinazzola A, Hirano M. MNGIE: from nuclear DNA to mitochondrial DNA. Neuromuscul Disord 2001; 11: 7-10. (Pubitemid 32106876)
22. Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn CD, et al. MNGIE: an autosomal recessive disorder due to thy-midine phosphorylase mutations. Ann Neurol 2000; 47: 792-800.
23. Okamura K, Santa T, Nagae K, Omae T. Congenital oculoskeletal my-opathy with abnormal muscle and liver mitochondria. J Neurol Sci 1976; 27: 79-91.
24. Papadimitriou A, Comi GP, Hadjigeorgiou GM, Bordoni A, Sciacco M, Napoli L, et al. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome. Neurology 1998; 51: 1086-92. (Pubitemid 28473405)
25. Petcharunpaisan S, Castillo M. Multiple cranial nerve enhancement in mitochondrial neurogastrointestinal encephalomyopathy. J Comput Assist Tomogr 2010; 34: 247-8.
26. Pontarin G, Ferraro P, Valentino ML, Hirano M, Reichard P, Bianchi V. Mitochondrial DNA depletion and thymidine phosphate pool dynamics in a cellular model of mitochondrial neurogastrointestinal encephalo-myopathy (MNGIE). J Biol Chem 2006; 281: 22720-8.
27. Poulton J, Hirano M, Spinazzola A, Arenas Hernandez M, Jardel C, Lombes A, et al. Collated mutations in mitochondrial DNA (mtDNA) depletion syndrome (excluding the mitochondrial gamma polymerase, POLG1). Biochim Biophys Acta 2009; 1792: 1109-12.
28. Said G, Lacroix C, Plante-Bordeneuve V, Messing B, Slama A, Crenn P, et al. Clinicopathological aspects of the neuropathy of neurogastroin-testinal encephalomyopathy (MNGIE) in four patients including two with a Charcot-Marie-Tooth presentation. J Neurol 2005; 252: 655-62. (Pubitemid 40864038)
29. Schüpbach WM, Benoist JF, Casali C, Elhasid R, Fay K, Hahn D, et al. Allogeneic hematopoetic stem cell transplantation (HSCT) for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Neurology, 2009, 73, 332.
30. Schüpbach WM, Vadday KM, Schaller A, Brekenfeld C, Kappeler L, Benoist JF, et al. Mitochondrial neurogastrointestinal encephalomyo-pathy in three siblings: clinical, genetic and neuroradiological features. J Neurol 2007, 254, 146-53.
31. Shaibani A, Shchelochkov OA, Zhang S, Katsonis P, Lichtarge O, Wong LJ, et al. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 2009; 66: 1028-32.
32. Spinazzola A, Marti R, Nishino I, Andreu A, Naini A, Tadesse S, et al. Altered thymidine metabolism due to defects of thymidine phosphor-ylase. J Biol Chem 2002; 277: 4128-33. (Pubitemid 34968672)
33. Szigeti K, Wong LJ, Perng CL, Saifi GM, Eldin K, Adesina AM, et al. MNGIE with lack of skeletal muscle involvement and a novel TP splice site mutation. J Med Genet 2004; 41: 125-9. (Pubitemid 38221751)
34. Valentino ML, Marti R, Tadesse S, Lopez LC, Manes JL, Lyzak J, et al. Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). FEBS Lett 2007; 581: 3410-4. (Pubitemid 47048186)
35. Van Goethem G, Schwartz M, Lofgren A, Dermaut B, Van Broeckhoven C, Vissing J. Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 2003; 11: 547-9. (Pubitemid 36896584)
36. Waltenberger J, Usuki K, Fellstrom B, Funa K, Heldin CH. Platelet-derived endothelial cell growth factor. Pharmacokinetics, organ distribution and degradation after intravenous administration in rats. FEBS Lett 1992; 313: 129-32.
37. Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim Biophys Acta 1990; 1034: 107-13. (Pubitemid 20114807)
38. Zimmer V, Feiden W, Becker G, Zimmer A, Reith W, Raedle J, et al. Absence of the interstitial cell of Cajal network in mitochondrial neu- rogastrointestinal encephalomyopathy. Neurogastroenterol Motil 2009; 21: 627-31.